AP-3200

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAP-3200
Drug Alias NameAP-3200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesArissa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArissa Pharma
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A